Selected research
Market Outlook & Growth Opportunities
Global Logistics in Pharmaceutical Market Outlook and Growth Opportunities 2026
Market perspective
The global Logistics in Pharmaceutical market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Logistics in Pharmaceutical is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Logistics in Pharmaceutical is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Logistics in Pharmaceutical is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Logistics in Pharmaceutical market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Logistics in Pharmaceutical market include Agility, Air Canada, CEVA Logistics, CH Robinson, DB Group, Deutsche Post, DSV, FedEx and Kuehne Nagel, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Logistics in Pharmaceutical market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Logistics in Pharmaceutical and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Logistics in Pharmaceutical revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Logistics in Pharmaceutical market.
Logistics in Pharmaceutical Segment by Company
Agility
Air Canada
CEVA Logistics
CH Robinson
DB Group
Deutsche Post
DSV
FedEx
Kuehne Nagel
Nippon Express
SF Express
VersaCold
Logistics in Pharmaceutical Segment by Type
Cold Chain Logistics
Non-Cold Chain Logistics
Logistics in Pharmaceutical Segment by Application
Pharmacies
Hospitals and Clinics
Logistics in Pharmaceutical Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Logistics in Pharmaceutical status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Logistics in Pharmaceutical key companies, revenue, market share, and recent developments.
3. To split the Logistics in Pharmaceutical breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Logistics in Pharmaceutical market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Logistics in Pharmaceutical significant trends, drivers, influence factors in global and regions.
6. To analyze Logistics in Pharmaceutical competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Logistics in Pharmaceutical market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Logistics in Pharmaceutical and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Logistics in Pharmaceutical.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Logistics in Pharmaceutical industry.
Chapter 3: Detailed analysis of Logistics in Pharmaceutical company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Logistics in Pharmaceutical in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Logistics in Pharmaceutical in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Cold Chain Logistics
- Non-Cold Chain Logistics
Applications
- Pharmacies
- Hospitals and Clinics
Companies covered
- Agility
- Air Canada
- CEVA Logistics
- CH Robinson
- DB Group
- Deutsche Post
- DSV
- FedEx
- Kuehne Nagel
- Nippon Express
- SF Express
- VersaCold
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Logistics in Pharmaceutical Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Logistics in Pharmaceutical Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Logistics in Pharmaceutical Market Dynamics
- 2.1 Logistics in Pharmaceutical Industry Trends
- 2.2 Logistics in Pharmaceutical Industry Drivers
- 2.3 Logistics in Pharmaceutical Industry Opportunities and Challenges
- 2.4 Logistics in Pharmaceutical Industry Restraints
3 Logistics in Pharmaceutical Market by Company
- 3.1 Global Logistics in Pharmaceutical Company Revenue Ranking in 2025
- 3.2 Global Logistics in Pharmaceutical Revenue by Company (2021-2026)
- 3.3 Global Logistics in Pharmaceutical Company Ranking (2024-2026)
- 3.4 Global Logistics in Pharmaceutical Company Manufacturing Base and Headquarters
- 3.5 Global Logistics in Pharmaceutical Company Product Type and Application
- 3.6 Global Logistics in Pharmaceutical Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Logistics in Pharmaceutical Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Logistics in Pharmaceutical Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Logistics in Pharmaceutical Market by Type
- 4.1 Logistics in Pharmaceutical Type Introduction
- 4.1.1 Cold Chain Logistics
- 4.1.2 Non-Cold Chain Logistics
- 4.2 Global Logistics in Pharmaceutical Sales Value by Type
- 4.2.1 Global Logistics in Pharmaceutical Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Logistics in Pharmaceutical Sales Value by Type (2021-2032)
- 4.2.3 Global Logistics in Pharmaceutical Sales Value Share by Type (2021-2032)
5 Logistics in Pharmaceutical Market by Application
- 5.1 Logistics in Pharmaceutical Application Introduction
- 5.1.1 Pharmacies
- 5.1.2 Hospitals and Clinics
- 5.2 Global Logistics in Pharmaceutical Sales Value by Application
- 5.2.1 Global Logistics in Pharmaceutical Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Logistics in Pharmaceutical Sales Value by Application (2021-2032)
- 5.2.3 Global Logistics in Pharmaceutical Sales Value Share by Application (2021-2032)
6 Logistics in Pharmaceutical Regional Value Analysis
- 6.1 Global Logistics in Pharmaceutical Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Logistics in Pharmaceutical Sales Value by Region (2021-2032)
- 6.2.1 Global Logistics in Pharmaceutical Sales Value by Region: 2021-2026
- 6.2.2 Global Logistics in Pharmaceutical Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Logistics in Pharmaceutical Sales Value (2021-2032)
- 6.3.2 North America Logistics in Pharmaceutical Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Logistics in Pharmaceutical Sales Value (2021-2032)
- 6.4.2 Europe Logistics in Pharmaceutical Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Logistics in Pharmaceutical Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Logistics in Pharmaceutical Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Logistics in Pharmaceutical Sales Value (2021-2032)
- 6.6.2 South America Logistics in Pharmaceutical Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Logistics in Pharmaceutical Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Logistics in Pharmaceutical Sales Value Share by Country, 2025 VS 2032
7 Logistics in Pharmaceutical Country-level Value Analysis
- 7.1 Global Logistics in Pharmaceutical Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Logistics in Pharmaceutical Sales Value by Country (2021-2032)
- 7.2.1 Global Logistics in Pharmaceutical Sales Value by Country (2021-2026)
- 7.2.2 Global Logistics in Pharmaceutical Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Logistics in Pharmaceutical Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Logistics in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Logistics in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Logistics in Pharmaceutical Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Logistics in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Logistics in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Logistics in Pharmaceutical Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Logistics in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Logistics in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Logistics in Pharmaceutical Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Logistics in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Logistics in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Logistics in Pharmaceutical Sales Value Growth Rate (2021-2032)
- 7.7.2 France Logistics in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Logistics in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Logistics in Pharmaceutical Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Logistics in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Logistics in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Logistics in Pharmaceutical Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Logistics in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Logistics in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Logistics in Pharmaceutical Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Logistics in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Logistics in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Logistics in Pharmaceutical Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Logistics in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Logistics in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Logistics in Pharmaceutical Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Logistics in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Logistics in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Logistics in Pharmaceutical Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Logistics in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Logistics in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Logistics in Pharmaceutical Sales Value Growth Rate (2021-2032)
- 7.14.2 China Logistics in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Logistics in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Logistics in Pharmaceutical Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Logistics in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Logistics in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Logistics in Pharmaceutical Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Logistics in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Logistics in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Logistics in Pharmaceutical Sales Value Growth Rate (2021-2032)
- 7.17.2 India Logistics in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Logistics in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Logistics in Pharmaceutical Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Logistics in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Logistics in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Logistics in Pharmaceutical Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Logistics in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Logistics in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Logistics in Pharmaceutical Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Logistics in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Logistics in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Logistics in Pharmaceutical Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Logistics in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Logistics in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Logistics in Pharmaceutical Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Logistics in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Logistics in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Logistics in Pharmaceutical Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Logistics in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Logistics in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Logistics in Pharmaceutical Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Logistics in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Logistics in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Logistics in Pharmaceutical Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Logistics in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Logistics in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Logistics in Pharmaceutical Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Logistics in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Logistics in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Logistics in Pharmaceutical Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Logistics in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Logistics in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Logistics in Pharmaceutical Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Logistics in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Logistics in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Logistics in Pharmaceutical Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Logistics in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Logistics in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Logistics in Pharmaceutical Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Logistics in Pharmaceutical Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Logistics in Pharmaceutical Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Agility
- 8.1.1 Agility Company Information
- 8.1.2 Agility Business Overview
- 8.1.3 Agility Logistics in Pharmaceutical Revenue and Gross Margin (2021-2026)
- 8.1.4 Agility Logistics in Pharmaceutical Product Portfolio
- 8.1.5 Agility Recent Developments
- 8.2 Air Canada
- 8.2.1 Air Canada Company Information
- 8.2.2 Air Canada Business Overview
- 8.2.3 Air Canada Logistics in Pharmaceutical Revenue and Gross Margin (2021-2026)
- 8.2.4 Air Canada Logistics in Pharmaceutical Product Portfolio
- 8.2.5 Air Canada Recent Developments
- 8.3 CEVA Logistics
- 8.3.1 CEVA Logistics Company Information
- 8.3.2 CEVA Logistics Business Overview
- 8.3.3 CEVA Logistics Logistics in Pharmaceutical Revenue and Gross Margin (2021-2026)
- 8.3.4 CEVA Logistics Logistics in Pharmaceutical Product Portfolio
- 8.3.5 CEVA Logistics Recent Developments
- 8.4 CH Robinson
- 8.4.1 CH Robinson Company Information
- 8.4.2 CH Robinson Business Overview
- 8.4.3 CH Robinson Logistics in Pharmaceutical Revenue and Gross Margin (2021-2026)
- 8.4.4 CH Robinson Logistics in Pharmaceutical Product Portfolio
- 8.4.5 CH Robinson Recent Developments
- 8.5 DB Group
- 8.5.1 DB Group Company Information
- 8.5.2 DB Group Business Overview
- 8.5.3 DB Group Logistics in Pharmaceutical Revenue and Gross Margin (2021-2026)
- 8.5.4 DB Group Logistics in Pharmaceutical Product Portfolio
- 8.5.5 DB Group Recent Developments
- 8.6 Deutsche Post
- 8.6.1 Deutsche Post Company Information
- 8.6.2 Deutsche Post Business Overview
- 8.6.3 Deutsche Post Logistics in Pharmaceutical Revenue and Gross Margin (2021-2026)
- 8.6.4 Deutsche Post Logistics in Pharmaceutical Product Portfolio
- 8.6.5 Deutsche Post Recent Developments
- 8.7 DSV
- 8.7.1 DSV Company Information
- 8.7.2 DSV Business Overview
- 8.7.3 DSV Logistics in Pharmaceutical Revenue and Gross Margin (2021-2026)
- 8.7.4 DSV Logistics in Pharmaceutical Product Portfolio
- 8.7.5 DSV Recent Developments
- 8.8 FedEx
- 8.8.1 FedEx Company Information
- 8.8.2 FedEx Business Overview
- 8.8.3 FedEx Logistics in Pharmaceutical Revenue and Gross Margin (2021-2026)
- 8.8.4 FedEx Logistics in Pharmaceutical Product Portfolio
- 8.8.5 FedEx Recent Developments
- 8.9 Kuehne Nagel
- 8.9.1 Kuehne Nagel Company Information
- 8.9.2 Kuehne Nagel Business Overview
- 8.9.3 Kuehne Nagel Logistics in Pharmaceutical Revenue and Gross Margin (2021-2026)
- 8.9.4 Kuehne Nagel Logistics in Pharmaceutical Product Portfolio
- 8.9.5 Kuehne Nagel Recent Developments
- 8.10 Nippon Express
- 8.10.1 Nippon Express Company Information
- 8.10.2 Nippon Express Business Overview
- 8.10.3 Nippon Express Logistics in Pharmaceutical Revenue and Gross Margin (2021-2026)
- 8.10.4 Nippon Express Logistics in Pharmaceutical Product Portfolio
- 8.10.5 Nippon Express Recent Developments
- 8.11 SF Express
- 8.11.1 SF Express Company Information
- 8.11.2 SF Express Business Overview
- 8.11.3 SF Express Logistics in Pharmaceutical Revenue and Gross Margin (2021-2026)
- 8.11.4 SF Express Logistics in Pharmaceutical Product Portfolio
- 8.11.5 SF Express Recent Developments
- 8.12 VersaCold
- 8.12.1 VersaCold Company Information
- 8.12.2 VersaCold Business Overview
- 8.12.3 VersaCold Logistics in Pharmaceutical Revenue and Gross Margin (2021-2026)
- 8.12.4 VersaCold Logistics in Pharmaceutical Product Portfolio
- 8.12.5 VersaCold Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst